Finally, the results of GSEA indicated that CASP4 is involved in the glioma-associated NLRP3-inflammation complex as well as immune signaling pathways such as T cell activation and proliferation and chemokine activation. This evidence concerns the gene CASP4 and central nervous system cancer.